Invention Grant
- Patent Title: Process for safely providing retinal phototherapy based on determination of RPE melanin levels
-
Application No.: US16241812Application Date: 2019-01-07
-
Publication No.: US10434330B2Publication Date: 2019-10-08
- Inventor: David B. Chang , Jeffrey K. Luttrull
- Applicant: Ojai Retinal Technology, LLC
- Applicant Address: US CA Ojai
- Assignee: Ojai Retinal Technology, LLC
- Current Assignee: Ojai Retinal Technology, LLC
- Current Assignee Address: US CA Ojai
- Agency: Kelly & Kelley, LLP
- Main IPC: A61N5/06
- IPC: A61N5/06 ; A61B3/10

Abstract:
A process for safely providing retinal phototherapy includes generating an interferometric signal or pattern by applying a near infrared light beam to a retinal pigment epithelium of a retina of an eye. A level or concentration of melanin within the retinal pigment epithelium of the retina is compared to a normal level or concentration using the detected interferometric signal or pattern. One or more treatment parameters of the retinal phototherapy is adjusted if the level or concentration of melanin in the retinal pigment epithelium of the eye exceeds the normal level or concentration by a predetermined amount.
Public/Granted literature
- US20190151676A1 PROCESS FOR SAFELY PROVIDING RETINAL PHOTOTHERAPY BASED ON DETERMINATION OF RPE MELANIN LEVELS Public/Granted day:2019-05-23
Information query